Sign Up
S 300 New York Senate · 2017 Regular Session

Designates Xylazine as a schedule III depressant controlled substance

Summary
Designates Xylazine as a schedule III depressant controlled substance.
Bill status died 3 of 5 stages cleared
Introduction
Jan 2017
Committee Review
Jan 2018
Senate Passage
Apr 2017
Assembly Passage
Governor
Introduced Jan 4, 2017 Last action Jan 3, 2018
Floor votes · Senate Apr 24, 2017

How they voted

46–1
Passed · 2 other
Total votes 49
Apr 24, 2017
D Democratic26
23 Yea 1 Nay 2
88% Yea
R Republican23
23 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
10
Key actions
1
Committee
3
Jan 3, 2018
Committee
REFERRED TO HEALTH
upper
Apr 24, 2017
Committee
REFERRED TO HEALTH
lower
Apr 24, 2017
Upper · Passed
PASSED SENATE
upper
Jan 4, 2017
Committee
REFERRED TO HEALTH
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.